PL443087A1 - Sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne - Google Patents

Sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne

Info

Publication number
PL443087A1
PL443087A1 PL443087A PL44308722A PL443087A1 PL 443087 A1 PL443087 A1 PL 443087A1 PL 443087 A PL443087 A PL 443087A PL 44308722 A PL44308722 A PL 44308722A PL 443087 A1 PL443087 A1 PL 443087A1
Authority
PL
Poland
Prior art keywords
classifying
therapeutic properties
cells due
msc cells
subject
Prior art date
Application number
PL443087A
Other languages
English (en)
Other versions
PL247114B1 (pl
Inventor
Natalia Rozwadowska
Magdalena Murzyn
Ewelina Tomecka
Joanna Zyprych-Walczak
Alicja Szabelska-Beręsewicz
Katarzyna Bocian
Anna Różycka
Tomasz KOLANOWSKI
Tomasz Odłak
Original Assignee
Polski Bank Komórek Macierzystych Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polski Bank Komórek Macierzystych Spółka Akcyjna filed Critical Polski Bank Komórek Macierzystych Spółka Akcyjna
Priority to PL443087A priority Critical patent/PL247114B1/pl
Publication of PL443087A1 publication Critical patent/PL443087A1/pl
Publication of PL247114B1 publication Critical patent/PL247114B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Evolutionary Biology (AREA)
  • Pregnancy & Childbirth (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne do zastosowania jako narzędzie do dopasowywania dawcy do biorcy. Dodatkowo, przedmiotem zgłoszenia jest również sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne wspierany komputerowo.
PL443087A 2022-12-08 2022-12-08 Sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne PL247114B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL443087A PL247114B1 (pl) 2022-12-08 2022-12-08 Sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL443087A PL247114B1 (pl) 2022-12-08 2022-12-08 Sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne

Publications (2)

Publication Number Publication Date
PL443087A1 true PL443087A1 (pl) 2024-06-10
PL247114B1 PL247114B1 (pl) 2025-05-19

Family

ID=91432133

Family Applications (1)

Application Number Title Priority Date Filing Date
PL443087A PL247114B1 (pl) 2022-12-08 2022-12-08 Sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne

Country Status (1)

Country Link
PL (1) PL247114B1 (pl)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014011407A2 (en) * 2012-07-12 2014-01-16 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
PL433374A1 (pl) * 2020-03-27 2021-10-04 Polski Bank Komórek Macierzystych Spółka Akcyjna Zastosowanie panelu genów do określania potencjału teratogennego komórek mezenchymalnych i pochodzenia perinatalnego

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014011407A2 (en) * 2012-07-12 2014-01-16 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
PL433374A1 (pl) * 2020-03-27 2021-10-04 Polski Bank Komórek Macierzystych Spółka Akcyjna Zastosowanie panelu genów do określania potencjału teratogennego komórek mezenchymalnych i pochodzenia perinatalnego

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALEKSANDRA MUSIAŁ-WYSOCKA, MARTA KOT, MACIEJ SUŁKOWSKI, BOGNA BADYRA, MARCIN MAJKA: "Int. J. Mol. Sci., 2019, 20, 1807;", MOLECULAR AND FUNCTIONAL VERIFICATION OF WHARTON’S JELLY MESENCHYMAL STEM CELLS (WJ-MSCS) PLURIPOTENCY, DOI: 10.3390/ijms20081807 *
DINESH BHARTI, SHARATH BELAME SHIVAKUMAR, JI-KWON PARK, IMRAN ULLAH, RAGHAVENDRA BAREGUNDI SUBBARAO, JI-SUNG PARK, SUNG-LIM LEE, B: "Cell Tissue Res, 2018, 372:51–65", COMPARATIVE ANALYSIS OF HUMAN WHARTON’S JELLY MESENCHYMAL STEM CELLS DERIVED FROM DIFFERENT PARTS OF THE SAME UMBILICAL CORD, DOI: DOI 10.1007/s00441-017-2699-4 *
TOMECKA, E.; LECH, W.; ZYCHOWICZ, M.; SARNOWSKA, A.; MURZYN, M.; OLDAK, T.; DOMANSKA-JANIK, K.; BUZANSKA, L.; ROZWADOWSKA, N.: "Cells, 2021, 10, 717", ASSESSMENT OF THE NEUROPROTECTIVE AND STEMNESS PROPERTIES OF HUMAN WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS UNDER VARIABLE (5% VS. 21%) AEROBIC CONDITIONS, DOI: https://doi.org/10.3390/cells10040717 *
YURIY PETRENKO, IRENA VACKOVA, KRISTYNA KEKULOVA, MILADA CHUDICKOVA, ZUZANA KOCI, KAROLINA TURNOVCOVA, HELENA KUPCOVA SKALNIKOVA, : "Scientific Reports, 2020, 10:4290", A COMPARATIVE ANALYSIS OF MULTIPOTENT MESENCHYMAL STROMAL CELLS DERIVED FROM DIFFERENT SOURCES, WITH A FOCUS ON NEUROREGENERATIVE POTENTIAL, DOI: https://doi.org/10.1038/s41598-020-61167-z *

Also Published As

Publication number Publication date
PL247114B1 (pl) 2025-05-19

Similar Documents

Publication Publication Date Title
CL2021000880A1 (es) Métodos y composiciones para editar arn
CO2022005378A2 (es) Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores
CL2020001730A1 (es) Método para el tratamiento de cáncer. (divisional solicitud 201702728)
CL2020002805A1 (es) Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526)
MX2025003310A (es) Integracion dirigida de acidos nucleicos
MX2020009309A (es) Composiciones de cartirina y métodos para su uso.
MX2019008872A (es) Prevencion y tratamiento de da?o o enfermedad osea y cartilago.
AR111184A1 (es) Poliamidas y métodos para producir los mismos
SA521421425B1 (ar) طريقة لاستخلاص زيت حيوي من كتلة حيوية طحلبية
MX2022000893A (es) Metodo de obtencion de mitocondrias de celulas y mitocondrias obtenidas.
BR112022027101A2 (pt) Anticorpos multiespecíficos que se ligam a bcma
CU20200068A7 (es) Glicoconjugados de precisión como herramientas terapéuticas
MX2016006551A (es) Preparacion de anticuerpos de cultivos de celula de ovario de hamster chino para conjugacion.
WO2020035848A3 (en) Stable liquid thrombin compositions
EA202091349A1 (ru) Способы культивирования клеток
DOP2022000003A (es) Métodos para el cultivo del virus de la peste porcina africana en células de macrófagos alveolares de pulmón porcino fetal
BR112021025116A2 (pt) Células linfocíticas ativadas e métodos de uso das mesmas para tratar câncer e condições infecciosas
MX2020001853A (es) Métodos para mejorar la viabilidad de los órganos.
CO2025012210A2 (es) Polimorfo como inhibidor de la proteína quinasa mek, método de preparación y uso del mismo
PL443087A1 (pl) Sposób klasyfikacji komórek MSC ze względu na właściwości terapeutyczne
CL2019003459A1 (es) Métodos de cultivo celular.
CO2024000763A2 (es) Composiciones y métodos de los anticuerpos anti-pacap
AR116481A1 (es) Biomaterial que comprende células madre derivadas de tejido adiposo y gelatina y método para producir el mismo
MX2022001888A (es) Método para la producción in vitro de tejido cartilaginoso hialino.
MX2025010510A (es) Composiciones y metodos para la regulacion epigenetica de la expresion de pcsk9